| First Author | Zhang L | Year | 2017 |
| Journal | J Natl Cancer Inst | Volume | 109 |
| Issue | 8 | PubMed ID | 28423402 |
| Mgi Jnum | J:245795 | Mgi Id | MGI:5915415 |
| Doi | 10.1093/jnci/djw332 | Citation | Zhang L, et al. (2017) Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer. J Natl Cancer Inst 109(8) |
| abstractText | Adenomatous polyposis coli (APC) is widely accepted as a tumor suppressor gene highly mutated in colorectal cancers (CRC). Mutation and inactivation of this gene is a key and early event almost uniquely observed in colorectal tumorigenesis. Alterations in the APC gene generate truncated gene products, leading to activation of the Wnt signaling pathway and deregulation of multiple other cellular processes. It has been a mystery why most patients with CRC retain a truncated APC protein, but accumulating evidence suggest that these C terminally truncated APC proteins may have gain of function properties beyond the well-established loss of tumor suppressive function. Here, we will review the evidence for both the loss of function and the gain of function of APC truncations and how together they contribute to CRC initiation and progression. |
